Argatroban
Showing 1 - 25 of 40
Acute Suspected Heparin-induced Thrombocytopenia.
Not yet recruiting
- Heparin-induced Thrombocytopenia
-
Paris, FranceHopital Bichat-Claude Bernard
Sep 28, 2023
Stable Coronary Artery Disease (CAD), Unstable Angina (Troponin Negative) Trial in Frankfurt am Main, Rotenburg an der Fulda
Completed
- Stable Coronary Artery Disease (CAD)
- Unstable Angina (Troponin Negative)
- Argatroban
-
Frankfurt am Main, Hessen, Germany
- +1 more
Feb 24, 2023
Respiratory Failure Trial in Beijing (Argatroban, unfractionated heparin)
Recruiting
- Respiratory Failure
- Argatroban
- unfractionated heparin
-
Beijing, Beijing, ChinaBing Sun
Nov 8, 2022
Heparin-induced Thrombocytopenia Trial in Lincoln (VLX-1005, Argatroban)
Completed
- Heparin-induced Thrombocytopenia
- VLX-1005
- Argatroban
-
Lincoln, NebraskaCelerion, Inc.
Jan 10, 2023
Anticoagulation in Patients on ECMO for Severe Lung Failure
Completed
- ARDS
- COVID-19
- Argatroban Injection
- Heparin
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Sep 18, 2023
Stroke Trial in ShenYang (rt-PA, Argatroban)
Completed
- Stroke
- rt-PA
- Argatroban
-
ShenYang, ChinaGeneral Hospital of ShenYang Military Region
Feb 20, 2022
Extracorporeal Membrane Oxygenation Complication, Anticoagulants and Bleeding Disorders Trial in Vienna (Argatroban,
Recruiting
- Extracorporeal Membrane Oxygenation Complication
- Anticoagulants and Bleeding Disorders
- Argatroban
- Unfractionated heparin
-
Vienna, AustriaMedical University of Vienna
Feb 4, 2022
Heparin-induced Thrombocytopenia Trial in Worldwide (Danaparoid Sodium, Argatroban)
Terminated
- Heparin-induced Thrombocytopenia
- Danaparoid Sodium
- Argatroban
-
Gainesville, Florida
- +34 more
Dec 6, 2022
Critically Ill Patients: Evaluation ofNovel Ecarin-based Bedside
Unknown status
- Heparin-induced Thrombocytopenia
- ECA-Test (Clot-Pro)
-
Vienna, AustriaMedical University of Vienna, General Hospital
Feb 12, 2021
Stroke, Ischemic Trial in Shenyang (Argatroban plus dual antiplatelet)
Completed
- Stroke, Ischemic
- Argatroban plus dual antiplatelet
-
Shenyang, Liaoning, ChinaGeneral Hospital of Shenyang Military Region
Jul 20, 2020
Ischemic Stroke Trial in ShenYang (intra-arterial cocktail therapy)
Recruiting
- Ischemic Stroke
- intra-arterial cocktail therapy
-
ShenYang, ChinaGeneral Hospital of Northern Theater Command
Nov 19, 2021
Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)
Not yet recruiting
- Thrombocytopenia, Immune
- Heparin Induced Thrombocytopenia
- VLX-1005
- Placebo
- (no location specified)
Mar 24, 2023
Acute Ischemic Stroke Trial in United States (Argatroban, Eptifibatide, Placebo)
Recruiting
- Acute Ischemic Stroke
- Argatroban
- +2 more
-
Birmingham, Alabama
- +95 more
Aug 2, 2021
Heparin-Induced Thrombocytopenia Trial (fondaparinux, argatroban or lepirudin)
Withdrawn
- Heparin-Induced Thrombocytopenia
- fondaparinux
- argatroban or lepirudin
- (no location specified)
Aug 12, 2019
Gynecologic Tumors, Venous Thromboembolism, Low Molecular Weight Heparin Trial in Wuhan (s-LMWH, LMWH, Argatroban)
Completed
- Gynecologic Neoplasms
- +3 more
- s-LMWH
- +2 more
-
Wuhan, Hubei, ChinaTongji Hospital
May 12, 2019
Coronary Artery Disease Trial in Belgium, New Zealand (Percutaneous Coronary Intervention with drug eluting stents)
Recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention with drug eluting stents
-
Antwerp, Belgium
- +7 more
Mar 11, 2022
Argatroban, Rt-PA Trial in Shenyang (Argatroban combined with rt-PA, rt-PA)
Terminated
- Argatroban, Rt-PA
- Argatroban combined with rt-PA
- rt-PA
-
Shenyang, Liaoning, ChinaGeneral Hospital of Shenyang Military Region
Nov 12, 2018
Chronic Kidney Disease, Patients Requiring Heparin Free Dialysis Treatments Trial in Worldwide (Heparin free dialysis technique,
Completed
- Chronic Kidney Disease
- Patients Requiring Heparin Free Dialysis Treatments
- Heparin free dialysis technique
- Evodial
-
Brussels, Belgium
- +9 more
Jan 7, 2022
Antiphospholipid Syndrome, Anticoagulant Drugs Trial in Clermont-Ferrand (Lupus anticoagulant testing)
Recruiting
- Antiphospholipid Syndrome
- Anticoagulant Drugs
- Lupus anticoagulant testing
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 13, 2022
Heparin-induced Thrombocytopenia, Heparin-induced Thrombocytopenia and Thrombosis Trial in Boston (Apixaban)
Terminated
- Heparin-induced Thrombocytopenia
- Heparin-induced Thrombocytopenia and Thrombosis
-
Boston, Massachusetts
- +2 more
Nov 29, 2020
Heparin-induced Thrombocytopenia, HIT, Platelet Activation Trial in Amiens (blood sample)
Recruiting
- Heparin-induced Thrombocytopenia
- +7 more
- blood sample
-
Amiens, FranceCHU Amiens
Sep 12, 2023
Achievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin Resistance Trial in Innsbruck
Completed
- Achievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin Resistance
- Argatroban
-
Innsbruck, AustriaMedical University Innsbruck / Department for General and Surgic
Nov 14, 2017
Coronary Artery Bypass Graft Surgery, Presence of Heparin/Platelet Factor 4 Antibody Trial in Boston (Argatroban and warfarin)
Terminated
- Coronary Artery Bypass Graft Surgery
- Presence of Heparin/Platelet Factor 4 Antibody
- Argatroban and warfarin
-
Boston, MassachusettsMassachusetts General Hospital
Oct 16, 2017
Stroke, Cerebral Ischemia Trial in Houston (Argatroban)
Completed
- Stroke
- Cerebral Ischemia
- Argatroban
-
Houston, TexasUniversity of Texas Health Science Center at Houston
Jun 20, 2017
Ischemic Stroke Trial in Houston (Low Dose Argatroban, High Dose Argatroban, rt-PA (alteplase))
Terminated
- Ischemic Stroke
- Low Dose Argatroban
- +2 more
-
Houston, TexasUniversity of Texas Health Science Center at Houston
Mar 31, 2017